Free Trial

Insider Selling: Dolby Laboratories (NYSE:DLB) SVP Sells 4,688 Shares of Stock

Dolby Laboratories logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Insider sale: SVP John Couling sold 4,688 Dolby shares on May 4 at an average price of $58.47 for $274,107, reducing his holding by 3.81% to 118,353 shares.
  • Dolby beat recent quarterly estimates with EPS of $1.37 (vs. $1.31 expected) and revenue of $395.6M (vs. $385.8M), and issued FY2026 guidance of $4.30–$4.45 EPS and Q3 guidance of $0.56–$0.71.
  • The company declared a $0.36 quarterly dividend (annualized $1.44, yield ~2.5%, ex-dividend May 12), while the stock traded near $58.11 with a market cap of about $5.55B and a consensus analyst target of roughly $90.75.
  • Interested in Dolby Laboratories? Here are five stocks we like better.

Dolby Laboratories (NYSE:DLB - Get Free Report) SVP John Couling sold 4,688 shares of the stock in a transaction on Monday, May 4th. The stock was sold at an average price of $58.47, for a total value of $274,107.36. Following the transaction, the senior vice president owned 118,353 shares in the company, valued at $6,920,099.91. The trade was a 3.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Dolby Laboratories Stock Down 1.6%

Shares of Dolby Laboratories stock traded down $0.93 during trading on Wednesday, reaching $58.11. The company's stock had a trading volume of 768,602 shares, compared to its average volume of 747,274. Dolby Laboratories has a 52 week low of $55.73 and a 52 week high of $78.28. The firm has a market cap of $5.55 billion, a PE ratio of 22.97 and a beta of 0.86. The business's 50-day moving average price is $62.48 and its 200-day moving average price is $64.42.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business had revenue of $395.63 million during the quarter, compared to analysts' expectations of $385.80 million. During the same quarter in the prior year, the business posted $1.34 earnings per share. Dolby Laboratories's revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities analysts predict that Dolby Laboratories will post 3.17 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, May 12th. Dolby Laboratories's dividend payout ratio (DPR) is presently 56.92%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in DLB. Royal Bank of Canada increased its position in shares of Dolby Laboratories by 3.5% during the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker's stock valued at $5,491,000 after buying an additional 2,298 shares during the period. Goldman Sachs Group Inc. boosted its stake in Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker's stock worth $20,043,000 after buying an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Dolby Laboratories by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker's stock worth $19,131,000 after purchasing an additional 12,598 shares during the period. Focus Partners Wealth purchased a new position in Dolby Laboratories in the 1st quarter worth approximately $390,000. Finally, EverSource Wealth Advisors LLC increased its stake in Dolby Laboratories by 273.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker's stock worth $193,000 after purchasing an additional 1,902 shares during the period. Hedge funds and other institutional investors own 58.56% of the company's stock.

Analyst Ratings Changes

Several research firms have commented on DLB. Wall Street Zen downgraded Dolby Laboratories from a "buy" rating to a "hold" rating in a research report on Saturday, January 31st. Weiss Ratings restated a "hold (c-)" rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Rosenblatt Securities restated a "buy" rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, January 30th. Finally, Barrington Research restated an "outperform" rating and issued a $90.00 price target on shares of Dolby Laboratories in a research report on Monday, April 27th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Dolby Laboratories currently has an average rating of "Moderate Buy" and a consensus target price of $90.75.

Get Our Latest Stock Report on DLB

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines